oxybutynin has been researched along with Myalgia in 4 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Myalgia: Painful sensation in the muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Loxoprofen (LOX) is a nonsteroidal anti-inflammatory drug (NSAID)." | 6.90 | Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial. ( Chen, Z; Hu, S; Li, Z; Lin, J; Shao, Z; Shi, Y; Wang, G; Xiao, W; Zhang, Z; Zhao, D; Zheng, Y, 2019) |
| "Loxoprofen (LOX) is a nonsteroidal anti-inflammatory drug (NSAID)." | 2.90 | Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial. ( Chen, Z; Hu, S; Li, Z; Lin, J; Shao, Z; Shi, Y; Wang, G; Xiao, W; Zhang, Z; Zhao, D; Zheng, Y, 2019) |
| "A strong need exists for the development of transdermal patch having improved bioavailability at the site of action with fewer side effects at off-target organs." | 1.48 | Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system. ( Katas, H; Rahman, KU; Razzaq, Z; Shahid, N; Siddique, MI; Waqas, MK, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, CS | 1 |
| Khandelwal, M | 1 |
| Shahid, N | 1 |
| Siddique, MI | 1 |
| Razzaq, Z | 1 |
| Katas, H | 1 |
| Waqas, MK | 1 |
| Rahman, KU | 1 |
| Zhao, D | 1 |
| Chen, Z | 1 |
| Hu, S | 1 |
| Lin, J | 1 |
| Shao, Z | 1 |
| Wang, G | 1 |
| Xiao, W | 1 |
| Zheng, Y | 1 |
| Zhang, Z | 1 |
| Shi, Y | 1 |
| Li, Z | 1 |
| Singla, N | 1 |
| Desjardins, PJ | 1 |
| Cosca, EB | 1 |
| Parulan, C | 1 |
| Arriaga, A | 1 |
| Poole, KC | 1 |
| Batz, DM | 1 |
| Chang, PD | 1 |
2 trials available for oxybutynin and Myalgia
| Article | Year |
|---|---|
Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; China; Double-Blind Meth | 2019 |
Delayed-onset muscle soreness: a pilot study to assess analgesic study design features.
Topics: Adult; Analgesics; Diclofenac; Double-Blind Method; Exercise; Female; Humans; Male; Myalgia; Pain Me | 2015 |
2 other studies available for oxybutynin and Myalgia
| Article | Year |
|---|---|
A novel transdermal drug-delivery patch for treating local muscular pain.
Topics: Administration, Cutaneous; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Diclofenac; Drug | 2018 |
Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Topics: Administration, Cutaneous; Animals; Biological Availability; Clonidine; Delayed-Action Preparations; | 2018 |